Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 110 entries
Sorted by: Best Match Show Resources per page
Estimation of oxyhaemoglobin and of methaemoglobin by a photoelectric method.

The Biochemical journal

Szigeti B.
PMID: 16747277
Biochem J. 1940 Nov;34(10):1460-3. doi: 10.1042/bj0341460.

No abstract available.

Cite
Szigeti B. Estimation of oxyhaemoglobin and of methaemoglobin by a photoelectric method. Biochem J. 1940;34(10):1460-3doi: 10.1042/bj0341460.
Szigeti, B. (1940). Estimation of oxyhaemoglobin and of methaemoglobin by a photoelectric method. The Biochemical journal, 34(10), 1460-3. https://doi.org/10.1042/bj0341460
Szigeti, B. "Estimation of oxyhaemoglobin and of methaemoglobin by a photoelectric method." The Biochemical journal vol. 34,10 (1940): 1460-3. doi: https://doi.org/10.1042/bj0341460
Szigeti B. Estimation of oxyhaemoglobin and of methaemoglobin by a photoelectric method. Biochem J. 1940 Nov;34(10):1460-3. doi: 10.1042/bj0341460. PMID: 16747277; PMCID: PMC1265434.
Copy Download .nbib Format: NLM
Experimental trichothecene mycotoxicosis produced in broiler chickens by Fusarium sporotrichiella var. sporotrichioides.

Avian pathology : journal of the W.V.P.A

Hoerr FJ, Carlton WW, Tuite J, Vesonder RF, Rohwedder WK, Szigeti G.
PMID: 18770204
Avian Pathol. 1982;11(3):385-405. doi: 10.1080/03079458208436113.

Fusarium sporotrichiella var. sporotrichioides (Bilay), cultured on . sterilised popcorn at 23 degrees C and then at 8 degrees C, 16 degrees C and 23 degrees C and fed as 50% of the diet, was lethal to 7-day-old male...

Cite
Hoerr FJ, Carlton WW, Tuite J, et al. Experimental trichothecene mycotoxicosis produced in broiler chickens by Fusarium sporotrichiella var. sporotrichioides. Avian Pathol. 1982;11(3):385-405doi: 10.1080/03079458208436113.
Hoerr, F. J., Carlton, W. W., Tuite, J., Vesonder, R. F., Rohwedder, W. K., & Szigeti, G. (1982). Experimental trichothecene mycotoxicosis produced in broiler chickens by Fusarium sporotrichiella var. sporotrichioides. Avian pathology : journal of the W.V.P.A, 11(3), 385-405. https://doi.org/10.1080/03079458208436113
Hoerr, F J, et al. "Experimental trichothecene mycotoxicosis produced in broiler chickens by Fusarium sporotrichiella var. sporotrichioides." Avian pathology : journal of the W.V.P.A vol. 11,3 (1982): 385-405. doi: https://doi.org/10.1080/03079458208436113
Hoerr FJ, Carlton WW, Tuite J, Vesonder RF, Rohwedder WK, Szigeti G. Experimental trichothecene mycotoxicosis produced in broiler chickens by Fusarium sporotrichiella var. sporotrichioides. Avian Pathol. 1982;11(3):385-405. doi: 10.1080/03079458208436113. PMID: 18770204.
Copy Download .nbib Format: NLM
Subleading Isgur-Wise form factor chi 3(v.

Physical review. D, Particles and fields

Ligeti Z, Neubert M, Nir Y.
PMID: 10015516
Phys Rev D Part Fields. 1993 Jun 01;47(11):5060-5066. doi: 10.1103/physrevd.47.5060.

No abstract available.

Cite
Ligeti Z, Neubert M, Nir Y. Subleading Isgur-Wise form factor chi 3(v. Phys Rev D Part Fields. 1993;47(11):5060-5066doi: 10.1103/physrevd.47.5060.
Ligeti, Z., Neubert, M., & Nir, Y. (1993). Subleading Isgur-Wise form factor chi 3(v. Physical review. D, Particles and fields, 47(11), 5060-5066. https://doi.org/10.1103/physrevd.47.5060
Ligeti, et al. "Subleading Isgur-Wise form factor chi 3(v." Physical review. D, Particles and fields vol. 47,11 (1993): 5060-5066. doi: https://doi.org/10.1103/physrevd.47.5060
Ligeti Z, Neubert M, Nir Y. Subleading Isgur-Wise form factor chi 3(v. Phys Rev D Part Fields. 1993 Jun 01;47(11):5060-5066. doi: 10.1103/physrevd.47.5060. PMID: 10015516.
Copy Download .nbib Format: NLM
Phenomenological constraints on Lambda -bar and lambda 1.

Physical review. D, Particles and fields

Ligeti Z, Nir Y.
PMID: 10017510
Phys Rev D Part Fields. 1994 May 01;49(9):R4331-R4334. doi: 10.1103/physrevd.49.r4331.

No abstract available.

Cite
Ligeti Z, Nir Y. Phenomenological constraints on Lambda -bar and lambda 1. Phys Rev D Part Fields. 1994;49(9):R4331-R4334doi: 10.1103/physrevd.49.r4331.
Ligeti, Z., & Nir, Y. (1994). Phenomenological constraints on Lambda -bar and lambda 1. Physical review. D, Particles and fields, 49(9), R4331-R4334. https://doi.org/10.1103/physrevd.49.r4331
Ligeti, and Nir. "Phenomenological constraints on Lambda -bar and lambda 1." Physical review. D, Particles and fields vol. 49,9 (1994): R4331-R4334. doi: https://doi.org/10.1103/physrevd.49.r4331
Ligeti Z, Nir Y. Phenomenological constraints on Lambda -bar and lambda 1. Phys Rev D Part Fields. 1994 May 01;49(9):R4331-R4334. doi: 10.1103/physrevd.49.r4331. PMID: 10017510.
Copy Download .nbib Format: NLM
High-frequency power spectra for systems subject to noise.

Physical review. A, General physics

Horsthemke W, Sigeti D.
PMID: 9898404
Phys Rev A Gen Phys. 1987 Mar 01;35(5):2276-2282. doi: 10.1103/physreva.35.2276.

No abstract available.

Cite
Horsthemke W, Sigeti D. High-frequency power spectra for systems subject to noise. Phys Rev A Gen Phys. 1987;35(5):2276-2282doi: 10.1103/physreva.35.2276.
Horsthemke, W., & Sigeti, D. (1987). High-frequency power spectra for systems subject to noise. Physical review. A, General physics, 35(5), 2276-2282. https://doi.org/10.1103/physreva.35.2276
Horsthemke, and Sigeti. "High-frequency power spectra for systems subject to noise." Physical review. A, General physics vol. 35,5 (1987): 2276-2282. doi: https://doi.org/10.1103/physreva.35.2276
Horsthemke W, Sigeti D. High-frequency power spectra for systems subject to noise. Phys Rev A Gen Phys. 1987 Mar 01;35(5):2276-2282. doi: 10.1103/physreva.35.2276. PMID: 9898404.
Copy Download .nbib Format: NLM
Capgras-like visual decomposition in Lewy body dementia with therapeutic response to donepezil.

Neurology. Clinical practice

Reimers K, Emmert N, Shah H, Benedict RH, Szigeti K.
PMID: 25566416
Neurol Clin Pract. 2014 Dec;4(6):467-469. doi: 10.1212/CPJ.0000000000000068.

No abstract available.

Cite
Reimers K, Emmert N, Shah H, et al. Capgras-like visual decomposition in Lewy body dementia with therapeutic response to donepezil. Neurol Clin Pract. 2014;4(6):467-469doi: 10.1212/CPJ.0000000000000068.
Reimers, K., Emmert, N., Shah, H., Benedict, R. H., & Szigeti, K. (2014). Capgras-like visual decomposition in Lewy body dementia with therapeutic response to donepezil. Neurology. Clinical practice, 4(6), 467-469. https://doi.org/10.1212/CPJ.0000000000000068
Reimers, Karen, et al. "Capgras-like visual decomposition in Lewy body dementia with therapeutic response to donepezil." Neurology. Clinical practice vol. 4,6 (2014): 467-469. doi: https://doi.org/10.1212/CPJ.0000000000000068
Reimers K, Emmert N, Shah H, Benedict RH, Szigeti K. Capgras-like visual decomposition in Lewy body dementia with therapeutic response to donepezil. Neurol Clin Pract. 2014 Dec;4(6):467-469. doi: 10.1212/CPJ.0000000000000068. PMID: 25566416; PMCID: PMC4277662.
Copy Download .nbib Format: NLM
Towards More Precise Determinations of the Quark Mixing Phase β.

Physical review letters

Ligeti Z, Robinson DJ.
PMID: 26722914
Phys Rev Lett. 2015 Dec 18;115(25):251801. doi: 10.1103/PhysRevLett.115.251801. Epub 2015 Dec 16.

We derive a new flavor symmetry relation for the determination of the weak phase β=ϕ_{1} from time-dependent CP asymmetries and B→J/ψP decay rates. In this relation, the contributions to sin2β proportional to V_{ub} are parametrically suppressed compared to the...

Cite
Ligeti Z, Robinson DJ. Towards More Precise Determinations of the Quark Mixing Phase β. Phys Rev Lett. 2015;115(25):251801doi: 10.1103/PhysRevLett.115.251801.
Ligeti, Z., & Robinson, D. J. (2015). Towards More Precise Determinations of the Quark Mixing Phase β. Physical review letters, 115(25), 251801. https://doi.org/10.1103/PhysRevLett.115.251801
Ligeti, Zoltan, and Robinson, Dean J. "Towards More Precise Determinations of the Quark Mixing Phase β." Physical review letters vol. 115,25 (2015): 251801. doi: https://doi.org/10.1103/PhysRevLett.115.251801
Ligeti Z, Robinson DJ. Towards More Precise Determinations of the Quark Mixing Phase β. Phys Rev Lett. 2015 Dec 18;115(25):251801. doi: 10.1103/PhysRevLett.115.251801. Epub 2015 Dec 16. PMID: 26722914.
Copy Download .nbib Format: NLM
Initial evidence of a 50% reduction of contrast media using digital variance angiography in endovascular carotid interventions.

European journal of radiology open

Óriás VI, Szöllősi D, Gyánó M, Veres DS, Nardai S, Csobay-Novák C, Nemes B, Kiss JP, Szigeti K, Osváth S, Sótonyi P, Ruzsa Z.
PMID: 33294499
Eur J Radiol Open. 2020 Nov 17;7:100288. doi: 10.1016/j.ejro.2020.100288. eCollection 2020.

PURPOSE: In previous clinical studies Digital Variance Angiography (DVA) provided higher signal-to-noise ratio (SNR) and better image quality than Digital Subtraction Angiography (DSA). Our aim was to investigate whether this quality reserve of DVA provides an opportunity for the...

Cite
Óriás VI, Szöllősi D, Gyánó M, et al. Initial evidence of a 50% reduction of contrast media using digital variance angiography in endovascular carotid interventions. Eur J Radiol Open. 2020;7:100288doi: 10.1016/j.ejro.2020.100288.
Óriás, V. I., Szöllősi, D., Gyánó, M., Veres, D. S., Nardai, S., Csobay-Novák, C., Nemes, B., Kiss, J. P., Szigeti, K., Osváth, S., Sótonyi, P., & Ruzsa, Z. (2020). Initial evidence of a 50% reduction of contrast media using digital variance angiography in endovascular carotid interventions. European journal of radiology open, 7100288. https://doi.org/10.1016/j.ejro.2020.100288
Óriás, Viktor I, et al. "Initial evidence of a 50% reduction of contrast media using digital variance angiography in endovascular carotid interventions." European journal of radiology open vol. 7 (2020): 100288. doi: https://doi.org/10.1016/j.ejro.2020.100288
Óriás VI, Szöllősi D, Gyánó M, Veres DS, Nardai S, Csobay-Novák C, Nemes B, Kiss JP, Szigeti K, Osváth S, Sótonyi P, Ruzsa Z. Initial evidence of a 50% reduction of contrast media using digital variance angiography in endovascular carotid interventions. Eur J Radiol Open. 2020 Nov 17;7:100288. doi: 10.1016/j.ejro.2020.100288. eCollection 2020. PMID: 33294499; PMCID: PMC7683322.
Copy Download .nbib Format: NLM
[No title available]

Stem cells international

Szepesi Á, Matula Z, Szigeti A, Várady G, Szalma J, Szabó G, Uher F, Sarkadi B, Német K.
PMID: 27999599
Stem Cells Int. 2016;2016:3595941. doi: 10.1155/2016/3595941. Epub 2016 Nov 24.

Bone tissue regeneration is a major, worldwide medical need, and several strategies have been developed to support the regeneration of extensive bone defects, including stem cell based bone grafts. In addition to the application of stem cells with high...

Cite
Szepesi Á, Matula Z, Szigeti A, et al. . Stem Cells Int. 2016;2016:3595941doi: 10.1155/2016/3595941.
Szepesi, �. �., Matula, Z., Szigeti, A., Várady, G., Szalma, J., Szabó, G., Uher, F., Sarkadi, B., & Német, K. (2016). . Stem cells international, 20163595941. https://doi.org/10.1155/2016/3595941
Szepesi, Áron, et al. "." Stem cells international vol. 2016 (2016): 3595941. doi: https://doi.org/10.1155/2016/3595941
Szepesi Á, Matula Z, Szigeti A, Várady G, Szalma J, Szabó G, Uher F, Sarkadi B, Német K. . Stem Cells Int. 2016;2016:3595941. doi: 10.1155/2016/3595941. Epub 2016 Nov 24. PMID: 27999599; PMCID: PMC5143785.
Copy Download .nbib Format: NLM
N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product.

Journal of pharmaceutical and biomedical analysis

Szabo M, Filep C, Nagy M, Sarkozy D, Szigeti M, Sperling E, Csanky E, Guttman A.
PMID: 34864596
J Pharm Biomed Anal. 2021 Nov 25;209:114483. doi: 10.1016/j.jpba.2021.114483. Epub 2021 Nov 25.

Omalizumab, a glycoprotein based biotherapeutics, is one of the most frequently used targeted antibody biopharmaceutical to reduce asthma exacerbations, improve lung function and reduce oral corticosteroid use. The effector function and clearance time of such glycoprotein drugs is affected...

Cite
Szabo M, Filep C, Nagy M, et al. N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product. J Pharm Biomed Anal. 2021;209:114483doi: 10.1016/j.jpba.2021.114483.
Szabo, M., Filep, C., Nagy, M., Sarkozy, D., Szigeti, M., Sperling, E., Csanky, E., & Guttman, A. (2021). N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product. Journal of pharmaceutical and biomedical analysis, 209114483. https://doi.org/10.1016/j.jpba.2021.114483
Szabo, Miklos, et al. "N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product." Journal of pharmaceutical and biomedical analysis vol. 209 (2021): 114483. doi: https://doi.org/10.1016/j.jpba.2021.114483
Szabo M, Filep C, Nagy M, Sarkozy D, Szigeti M, Sperling E, Csanky E, Guttman A. N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product. J Pharm Biomed Anal. 2021 Nov 25;209:114483. doi: 10.1016/j.jpba.2021.114483. Epub 2021 Nov 25. PMID: 34864596.
Copy Download .nbib Format: NLM
N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product.

Journal of pharmaceutical and biomedical analysis

Szabo M, Filep C, Nagy M, Sarkozy D, Szigeti M, Sperling E, Csanky E, Guttman A, Wu G.
PMID: 34864596
J Pharm Biomed Anal. 2021 Nov 25;209:114483. doi: 10.1016/j.jpba.2021.114483. Epub 2021 Nov 25.

Omalizumab, a glycoprotein based biotherapeutics, is one of the most frequently used targeted antibody biopharmaceutical to reduce asthma exacerbations, improve lung function and reduce oral corticosteroid use. The effector function and clearance time of such glycoprotein drugs is affected...

Cite
Szabo M, Filep C, Nagy M, et al. N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product. J Pharm Biomed Anal. 2021;209:114483doi: 10.1016/j.jpba.2021.114483.
Szabo, M., Filep, C., Nagy, M., Sarkozy, D., Szigeti, M., Sperling, E., Csanky, E., Guttman, A., & Wu, G. (2021). N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product. Journal of pharmaceutical and biomedical analysis, 209114483. https://doi.org/10.1016/j.jpba.2021.114483
Szabo, Miklos, et al. "N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product." Journal of pharmaceutical and biomedical analysis vol. 209 (2021): 114483. doi: https://doi.org/10.1016/j.jpba.2021.114483
Szabo M, Filep C, Nagy M, Sarkozy D, Szigeti M, Sperling E, Csanky E, Guttman A, Wu G. N-glycosylation structure - function characterization of omalizumab, an anti-asthma biotherapeutic product. J Pharm Biomed Anal. 2021 Nov 25;209:114483. doi: 10.1016/j.jpba.2021.114483. Epub 2021 Nov 25. PMID: 34864596.
Copy Download .nbib Format: NLM
Precision Global Determination of the B→X_{s}γ Decay Rate.

Physical review letters

Bernlochner FU, Lacker H, Ligeti Z, Stewart IW, Tackmann FJ, Tackmann K.
PMID: 34533343
Phys Rev Lett. 2021 Sep 03;127(10):102001. doi: 10.1103/PhysRevLett.127.102001.

We perform the first global fit to inclusive B→X_{s}γ measurements using a model-independent treatment of the nonperturbative b-quark distribution function, with next-to-next-to-leading logarithmic resummation and O(α_{s}^{2}) fixed-order contributions. The normalization of the B→X_{s}γ decay rate, given by |C_{7}^{incl}V_{tb}V_{ts}^{*}|^{2}, is...

Cite
Bernlochner FU, Lacker H, Ligeti Z, et al. Precision Global Determination of the B→X_{s}γ Decay Rate. Phys Rev Lett. 2021;127(10):102001doi: 10.1103/PhysRevLett.127.102001.
Bernlochner, F. U., Lacker, H., Ligeti, Z., Stewart, I. W., Tackmann, F. J., Tackmann, K. (2021). Precision Global Determination of the B→X_{s}γ Decay Rate. Physical review letters, 127(10), 102001. https://doi.org/10.1103/PhysRevLett.127.102001
Bernlochner, Florian U, et al. "Precision Global Determination of the B→X_{s}γ Decay Rate." Physical review letters vol. 127,10 (2021): 102001. doi: https://doi.org/10.1103/PhysRevLett.127.102001
Bernlochner FU, Lacker H, Ligeti Z, Stewart IW, Tackmann FJ, Tackmann K. Precision Global Determination of the B→X_{s}γ Decay Rate. Phys Rev Lett. 2021 Sep 03;127(10):102001. doi: 10.1103/PhysRevLett.127.102001. PMID: 34533343.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 110 entries